These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22461187)

  • 41. Association of anti-cyclic citrullinated protein antibodies, erosions, and rheumatoid factor with disease activity and work productivity: A patient registry study.
    Alemao E; Guo Z; Frits ML; Iannaccone CK; Shadick NA; Weinblatt ME
    Semin Arthritis Rheum; 2018 Apr; 47(5):630-638. PubMed ID: 29241640
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An examination of work instability, functional impairment, and disease activity in employed patients with rheumatoid arthritis.
    Macedo A; Oakley S; Gullick N; Kirkham B
    J Rheumatol; 2009 Feb; 36(2):225-30. PubMed ID: 19208557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: an analysis based on ESPOIR cohort data.
    Fautrel B; Combe B; Rincheval N; Dougados M;
    Ann Rheum Dis; 2012 Mar; 71(3):386-9. PubMed ID: 22039167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sick leave and work disability in patients with early arthritis.
    Zirkzee EJ; Sneep AC; de Buck PD; Allaart CF; Peeters AJ; Ronday HK; Westedt ML; le Cessie S; Vliet Vlieland TP
    Clin Rheumatol; 2008 Jan; 27(1):11-9. PubMed ID: 17492248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.
    Manders SH; Kievit W; Braakman-Jansen AL; Brus HL; Hendriks L; Fransen J; van de Laar MA; van Riel PL
    J Rheumatol; 2014 Jul; 41(7):1263-9. PubMed ID: 24833758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Markers of progression to rheumatoid arthritis: discriminative value of the new ACR/EULAR rheumatoid arthritis criteria in a Portuguese population with early polyarthritis.
    Mourão AF; Canhão H; Moura RA; Cascão R; Weinmann P; Rodrigues A; Polido-Pereira J; Resende C; Capela S; Silva JA; Fonseca JE
    Acta Reumatol Port; 2011; 36(4):370-6. PubMed ID: 22472927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers].
    Benucci M; Turchini S; Parrochi P; Boccaccini P; Manetti R; Cammelli E; Manfredi M
    Recenti Prog Med; 2006 Mar; 97(3):134-9. PubMed ID: 16700418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis Register.
    Humphreys JH; Verstappen SM; Mirjafari H; Bunn D; Lunt M; Bruce IN; Symmons DP
    Arthritis Care Res (Hoboken); 2013 Jan; 65(1):122-6. PubMed ID: 22556112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis.
    Emad Y; Shehata M; Ragab Y; Saad A; Hamza H; Abou-Zeid A
    Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Has the severity of rheumatoid arthritis at presentation diminished over time?
    Diffin JG; Lunt M; Marshall T; Chipping JR; Symmons DP; Verstappen SM
    J Rheumatol; 2014 Aug; 41(8):1590-9. PubMed ID: 24986850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in sociodemographic characteristics at baseline in two Swedish cohorts of patients with early rheumatoid arthritis diagnosed 1996-98 and 2006-09.
    Hallert E; Husberg M; Kalkan A; Rahmqvist M; Skogh T; Bernfort L
    Scand J Rheumatol; 2015; 44(2):100-5. PubMed ID: 25352338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis.
    Ateş A; Karaaslan Y; Aksaray S
    Clin Rheumatol; 2007 Apr; 26(4):499-504. PubMed ID: 16670828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort.
    Holdren M; Schieir O; Bartlett SJ; Bessette L; Boire G; Hazlewood G; Hitchon CA; Keystone E; Tin D; Thorne C; Bykerk VP; Pope JE;
    Arthritis Rheumatol; 2021 Jan; 73(1):53-60. PubMed ID: 32852109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-limiting arthritis among patients fulfilling the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in a very early arthritis cohort.
    Norli ES; Brinkmann GH; Kvien TK; Bjørneboe O; Haugen AJ; Nygaard H; Thunem C; Lie E; Mjaavatten MD
    Semin Arthritis Rheum; 2016 Dec; 46(3):272-278. PubMed ID: 27546493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
    Mouterde G; Lukas C; Goupille P; Flipo RM; Rincheval N; Daurès JP; Combe B
    J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
    Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF
    Ann Rheum Dis; 2011 Sep; 70(9):1575-80. PubMed ID: 21571731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes.
    Barra L; Bykerk V; Pope JE; Haraoui BP; Hitchon CA; Thorne JC; Keystone EC; Boire G;
    J Rheumatol; 2013 Aug; 40(8):1259-67. PubMed ID: 23378461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
    Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
    Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.